A Serra1, G Polese, C Braggion, A Rossi. 1. Centro Regionale Fibrosi Cistica, Azienda Ospedaliera di Verona, Ospedale Civile Maggiore di Borgo Trento, Verona, Italy.
Abstract
BACKGROUND:Patients with advanced cystic fibrosis can benefit from non-invasive positive pressure ventilation (NPPV) for the treatment of acute decompensation as well as for the management of chronic respiratory failure. This study was undertaken to compare the physiological effects of non-invasive proportional assist ventilation (PAV) and pressure support ventilation (PSV) on ventilatory pattern, transcutaneous blood gas tensions, and diaphragmatic effort in stable patients with cystic fibrosis and chronic CO2 retention. METHODS: In 12 patients two periods of spontaneous breathing were followed randomly by PSV (12 (3) cm H2O) and PAV (flow assist 4.9 (1.3) cm H2O/l.s, volume assist 18.9 (5.1) cm H2O/l) set for the patient's comfort and administered for 40 minutes with 2 cm H2O continuous positive airway pressure. Ventilatory pattern, transcutaneous blood gas tensions, and surface diaphragmatic electromyography were measured in the last 10 minutes of each application. RESULTS: On average, both PSV and PAV improved ventilation (+30%), tidal volume (+30%), and transcutaneous CO2 (-7%) while reducing diaphragmatic activity (-30% with PSV, -20% with PAV). Mean inspiratory airway pressure was lower during PAV than during PSV (9.7 (1.9) and 12.9 (2.7) cm H2O, respectively; p<0.05). The mean coefficient of variation of tidal volume was about 20% (range 11-39%) during spontaneous breathing and did not change with either PAV or PSV. CONCLUSIONS: These results show that short term administration of nasal PAV and PSV to patients with stable cystic fibrosis with chronic respiratory insufficiency is well tolerated, improves ventilation and blood gas tensions, and unloads the diaphragm.
RCT Entities:
BACKGROUND:Patients with advanced cystic fibrosis can benefit from non-invasive positive pressure ventilation (NPPV) for the treatment of acute decompensation as well as for the management of chronic respiratory failure. This study was undertaken to compare the physiological effects of non-invasive proportional assist ventilation (PAV) and pressure support ventilation (PSV) on ventilatory pattern, transcutaneous blood gas tensions, and diaphragmatic effort in stable patients with cystic fibrosis and chronic CO2 retention. METHODS: In 12 patients two periods of spontaneous breathing were followed randomly by PSV (12 (3) cm H2O) and PAV (flow assist 4.9 (1.3) cm H2O/l.s, volume assist 18.9 (5.1) cm H2O/l) set for the patient's comfort and administered for 40 minutes with 2 cm H2O continuous positive airway pressure. Ventilatory pattern, transcutaneous blood gas tensions, and surface diaphragmatic electromyography were measured in the last 10 minutes of each application. RESULTS: On average, both PSV and PAV improved ventilation (+30%), tidal volume (+30%), and transcutaneous CO2 (-7%) while reducing diaphragmatic activity (-30% with PSV, -20% with PAV). Mean inspiratory airway pressure was lower during PAV than during PSV (9.7 (1.9) and 12.9 (2.7) cm H2O, respectively; p<0.05). The mean coefficient of variation of tidal volume was about 20% (range 11-39%) during spontaneous breathing and did not change with either PAV or PSV. CONCLUSIONS: These results show that short term administration of nasal PAV and PSV to patients with stable cystic fibrosis with chronic respiratory insufficiency is well tolerated, improves ventilation and blood gas tensions, and unloads the diaphragm.
Authors: S Grasso; F Puntillo; L Mascia; G Ancona; T Fiore; F Bruno; A S Slutsky; V M Ranieri Journal: Am J Respir Crit Care Med Date: 2000-03 Impact factor: 21.405
Authors: V M Ranieri; R Giuliani; L Mascia; S Grasso; V Petruzzelli; N Puntillo; G Perchiazzi; T Fiore; A Brienza Journal: J Appl Physiol (1985) Date: 1996-07
Authors: U Pradal; G Polese; C Braggion; R Poggi; L Zanolla; G Mastella; A Rossi Journal: Am J Respir Crit Care Med Date: 1994-07 Impact factor: 21.405
Authors: Martijn G Slieker; Josephus P J van Gestel; Harry G M Heijerman; Gerdien A Tramper-Stranders; Ferdinand Teding van Berkhout; Cornelis K van der Ent; Nicolaas J G Jansen Journal: Intensive Care Med Date: 2006-03-02 Impact factor: 17.440
Authors: Miguel Fernández-Vivas; Juan Caturla-Such; Javier González de la Rosa; José Acosta-Escribano; Bernabé Alvarez-Sánchez; José Cánovas-Robles Journal: Intensive Care Med Date: 2003-06-12 Impact factor: 17.440